title: NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors.forename: E
authors.initials: E
authors.lastname: Berman
authors.forename: R A
authors.initials: RA
authors.lastname: Clift
authors.forename: E A
authors.initials: EA
authors.lastname: Copelan
authors.forename: P D
authors.initials: PD
authors.lastname: Emanuel
authors.forename: H P
authors.initials: HP
authors.lastname: Erba
authors.forename: M J
authors.initials: MJ
authors.lastname: Glenn
authors.forename: P L
authors.initials: PL
authors.lastname: Greenberg
authors.forename: R J
authors.initials: RJ
authors.lastname: Jones
authors.forename: S
authors.initials: S
authors.lastname: O'Brien
authors.forename: H I
authors.initials: HI
authors.lastname: Saba
authors.forename: R
authors.initials: R
authors.lastname: Schilder
authors.forename: D S
authors.initials: DS
authors.lastname: Snyder
authors.forename: R J
authors.initials: RJ
authors.lastname: Soiffer
authors.forename: M S
authors.initials: MS
authors.lastname: Tallman
authors.forename: M
authors.initials: M
authors.lastname: Wetzler
authors.forename: F
authors.initials: F
authors.lastname: Ravandi-Kashani
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
authors.forename: M
authors.initials: M
authors.lastname: Talpaz
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy; D008991:Monitoring, Physiologic; D012008:Recurrence; D014184:Transplantation, Homologous; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha